Literature DB >> 11313373

Engineering of macrophages to produce IFN-gamma in response to hypoxia.

L Carta1, S Pastorino, G Melillo, M C Bosco, S Massazza, L Varesio.   

Abstract

Activation of murine macrophages (Mphi) requires the collaboration of signals derived from the immune system and the environment. In this study, we engineered a murine Mphi cell line to become activated in response to an environmental signal, hypoxia, as the sole stimulus. Hypoxia is a condition of low oxygen tension, occurring in several pathological tissues, which acts in synergy with IFN-gamma to induce full Mphi activation. We transfected the ANA-1 murine Mphi cell line with a construct containing the IFN-gamma gene controlled by a synthetic promoter inducible by hypoxia (HRE3x-Tk), and we characterized the cellular and molecular biology of the engineered Mphi under normoxia or hypoxia. Engineered Mphi in normoxia expressed basal levels of IFN-gamma mRNA and protein that were strongly augmented by shifting the cells to hypoxia. Furthermore, they responded to the synthesized IFN-gamma with induction of IFN-responsive factor-1 and 2'-5'-oligoadenylate synthase expression. Under normoxic conditions, the engineered Mphi had a significant constitutive level of Ia Ags and Fc receptors. Hypoxia induced further augmentation of Ia and Fc expression. Finally, hypoxia induced inducible NO synthase expression, and subsequent reoxygenation led to the production of NO. In conclusion, the engineered Mphi, which produce IFN-gamma in an inducible manner, express new biochemical and functional properties in response to low oxygen environment as the sole stimulus, thereby circumventing the need for costimulation by other immune system-derived signals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313373     DOI: 10.4049/jimmunol.166.9.5374

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Non-cell-autonomous tumor suppression: oncogene-provoked apoptosis promotes tumor cell senescence via stromal crosstalk.

Authors:  Maurice Reimann; Clemens A Schmitt; Soyoung Lee
Journal:  J Mol Med (Berl)       Date:  2011-05-19       Impact factor: 4.599

2.  Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction.

Authors:  Paolo Fardin; Andrea Cornero; Annalisa Barla; Sofia Mosci; Massimo Acquaviva; Lorenzo Rosasco; Claudio Gambini; Alessandro Verri; Luigi Varesio
Journal:  J Biomed Biotechnol       Date:  2010-06-28

3.  Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy.

Authors:  Bernard Burke; Athina Giannoudis; Kevin P Corke; Dalvir Gill; Michael Wells; Loems Ziegler-Heitbrock; Claire E Lewis
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

4.  Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients.

Authors:  Davide Cangelosi; Fabiola Blengio; Rogier Versteeg; Angelika Eggert; Alberto Garaventa; Claudio Gambini; Massimo Conte; Alessandra Eva; Marco Muselli; Luigi Varesio
Journal:  BMC Bioinformatics       Date:  2013-04-22       Impact factor: 3.169

5.  A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.

Authors:  Paolo Fardin; Annalisa Barla; Sofia Mosci; Lorenzo Rosasco; Alessandro Verri; Rogier Versteeg; Huib N Caron; Jan J Molenaar; Ingrid Ora; Alessandra Eva; Maura Puppo; Luigi Varesio
Journal:  Mol Cancer       Date:  2010-07-12       Impact factor: 27.401

6.  A data-driven computational model enables integrative and mechanistic characterization of dynamic macrophage polarization.

Authors:  Chen Zhao; Thalyta X Medeiros; Richard J Sové; Brian H Annex; Aleksander S Popel
Journal:  iScience       Date:  2021-01-29

7.  The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.

Authors:  Paolo Fardin; Annalisa Barla; Sofia Mosci; Lorenzo Rosasco; Alessandro Verri; Luigi Varesio
Journal:  BMC Genomics       Date:  2009-10-15       Impact factor: 3.969

8.  Macrophages in malignant pleural effusions - alternatively activated tumor associated macrophages.

Authors:  Mariusz Kaczmarek; Jan Sikora
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.